Molina Healthcare (NYSE:MOH) Price Target Lowered to $353.00 at Deutsche Bank Aktiengesellschaft

Molina Healthcare (NYSE:MOH) had its price objective decreased by analysts at Deutsche Bank Aktiengesellschaft from $354.00 to $353.00 in a report released on Monday, Benzinga reports. The firm presently has a “hold” rating on the stock. Deutsche Bank Aktiengesellschaft’s price target would indicate a potential upside of 6.23% from the stock’s previous close.

Several other equities research analysts have also issued reports on MOH. Jefferies Financial Group reduced their price target on Molina Healthcare from $354.00 to $297.00 and set a “hold” rating for the company in a report on Wednesday, July 24th. Wells Fargo & Company decreased their price objective on shares of Molina Healthcare from $375.00 to $315.00 and set an “equal weight” rating for the company in a report on Monday, July 22nd. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $406.00 price target on shares of Molina Healthcare in a research report on Tuesday, July 23rd. JPMorgan Chase & Co. reduced their target price on Molina Healthcare from $420.00 to $395.00 and set an “overweight” rating for the company in a report on Wednesday, July 10th. Finally, Baird R W raised shares of Molina Healthcare to a “strong-buy” rating in a research report on Thursday, May 30th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Molina Healthcare presently has an average rating of “Moderate Buy” and a consensus target price of $374.25.

Molina Healthcare Price Performance

Shares of NYSE:MOH traded down $3.06 during trading hours on Monday, hitting $332.30. 284,420 shares of the company’s stock traded hands, compared to its average volume of 483,306. The company’s fifty day simple moving average is $306.95 and its two-hundred day simple moving average is $352.98. The company has a market cap of $19.47 billion, a price-to-earnings ratio of 18.07, a price-to-earnings-growth ratio of 1.10 and a beta of 0.58. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.57 and a current ratio of 1.57. Molina Healthcare has a 52 week low of $282.96 and a 52 week high of $423.92.

Molina Healthcare (NYSE:MOH) last released its earnings results on Wednesday, July 24th. The company reported $5.86 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.73 by $0.13. Molina Healthcare had a net margin of 2.84% and a return on equity of 28.09%. The company had revenue of $9.88 billion during the quarter, compared to the consensus estimate of $9.75 billion. During the same quarter in the prior year, the firm earned $5.65 EPS. The company’s revenue was up 18.7% compared to the same quarter last year. As a group, equities analysts anticipate that Molina Healthcare will post 23.16 EPS for the current fiscal year.

Insider Transactions at Molina Healthcare

In other Molina Healthcare news, Director Ronna Romney sold 250 shares of the company’s stock in a transaction that occurred on Tuesday, May 21st. The stock was sold at an average price of $343.27, for a total value of $85,817.50. Following the completion of the transaction, the director now owns 16,945 shares of the company’s stock, valued at approximately $5,816,710.15. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other news, COO James Woys sold 10,000 shares of the stock in a transaction that occurred on Wednesday, May 22nd. The stock was sold at an average price of $345.15, for a total value of $3,451,500.00. Following the completion of the transaction, the chief operating officer now directly owns 53,613 shares of the company’s stock, valued at approximately $18,504,526.95. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Ronna Romney sold 250 shares of the business’s stock in a transaction on Tuesday, May 21st. The shares were sold at an average price of $343.27, for a total value of $85,817.50. Following the completion of the sale, the director now directly owns 16,945 shares in the company, valued at approximately $5,816,710.15. The disclosure for this sale can be found here. Insiders own 1.10% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Norges Bank bought a new stake in Molina Healthcare during the 4th quarter worth approximately $275,143,000. Wellington Management Group LLP boosted its stake in Molina Healthcare by 12.8% in the fourth quarter. Wellington Management Group LLP now owns 3,831,100 shares of the company’s stock worth $1,384,215,000 after purchasing an additional 436,060 shares in the last quarter. Swedbank AB bought a new stake in shares of Molina Healthcare during the first quarter worth $69,320,000. Capital Research Global Investors increased its stake in shares of Molina Healthcare by 5.4% in the fourth quarter. Capital Research Global Investors now owns 2,430,283 shares of the company’s stock valued at $878,086,000 after buying an additional 123,894 shares in the last quarter. Finally, The Manufacturers Life Insurance Company increased its stake in shares of Molina Healthcare by 127.0% in the fourth quarter. The Manufacturers Life Insurance Company now owns 192,847 shares of the company’s stock valued at $69,678,000 after buying an additional 107,895 shares in the last quarter. 98.50% of the stock is owned by institutional investors.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.